Sarepta Therapeutics (SRPT) Net Equity Issued and Repurchased (2010 - 2026)
Sarepta Therapeutics' Net Equity Issued and Repurchased came in at $241,000 for Q1 2026, down 98.5% from $15.68 million a year earlier.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
For FY2025, Sarepta Therapeutics' Net Equity Issued and Repurchased was $20 million, down 74.9% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -42.3% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $79.53 million in FY2024 (+55.2%), $51.25 million in FY2023 (+70.6%), $30.04 million in FY2022 (+44.4%) and $20.8 million in FY2021 (-93.3%).
- The Q1 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q4 2019.
- Year-over-year, Net Equity Issued and Repurchased increased in two of the last seven quarters, with growth averaging 51.1%.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2024 (growth of 581.1%), and the weakest in Q4 2021 (a decline of 99.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Sarepta Therapeutics | 1.92 Bn | -1.31 Bn | 251.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 241,000.00 |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 13.76 Mn |
| Jun 30, 2024 | 39.92 Mn |
| Mar 31, 2024 | 22.14 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 15.41 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 28.04 Mn |
| Dec 31, 2022 | 11.30 Mn |
| Sep 30, 2022 | 13.41 Mn |
| Jun 30, 2022 | 339,000.00 |
| Mar 31, 2022 | 4.99 Mn |
| Dec 31, 2021 | 2.15 Mn |
| Sep 30, 2021 | 5.90 Mn |
| Jun 30, 2021 | 3.53 Mn |
| Mar 31, 2021 | 9.23 Mn |
API Access
Sarepta Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();